Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dario Health Corp (NQ: DRIO )

0.8002 -0.0298 (-3.59%)
Streaming Delayed Price Updated: 9:50 AM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dario Health Corp

< Previous 1 2 3 4 5 6 7 Next >
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Enters New Contract with National Employer
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Partners with Solera Health for Added Hypertension Management Solutions
Via Investor Brand Network
DarioHealth Earnings Perspective: Return On Capital Employed
According to data from Benzinga Pro, during Q1, DarioHealth's (NASDAQ:DRIO) reported sales totaled $8.06 million. Despite a 26.27% increase in earnings, the company posted a loss of $15.92 million. 
Via Benzinga
Dario Health (DRIO) Poised To Inflect Upon Full Launch of National Health Plan Rumored To Be Aetna (AET)
Dario Health (DRIO) Poised to Inflect Upon Full Launch of National Health Plan Rumored to be Aetna (AET) - Fundamentals: Company positioned to avoid dilutive financing after... 
Via Benzinga
Recap: DarioHealth Q1 Earnings
DarioHealth (NASDAQ:DRIO) reported its Q1 earnings results on Thursday, May 12, 2022 at 06:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Recap: DarioHealth Q4 Earnings
DarioHealth (NASDAQ:DRIO) reported its Q4 earnings results on Tuesday, March 22, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
DarioHealth Earnings Preview
DarioHealth (NASDAQ:DRIO) is set to give its latest quarterly earnings report on Monday, 2022-03-21. Here's what investors need to know before the announcement. Analysts estimate... 
Via Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Partners with OrbiMed to Close on $50 Million Credit Facility
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Presenting Key Findings from Three New Studies at ADA Scientific Sessions
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Enters New Commercial Contracts as Market Develops Appreciation for Integrated Digital Solutions
Via Investor Brand Network
Cowen & Co. Maintains Outperform Rating for DarioHealth: Here's What You Need To Know
Cowen & Co. has decided to maintain its Outperform rating of DarioHealth (NASDAQ:DRIO) and raise its price target from $14.00 to $18.00. Shares of DarioHealth are trading up 5.8% over the last 24... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 13, 2022
Upgrades 
Via Benzinga
90 Biggest Movers From Yesterday
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered... 
Via Benzinga
58 Stocks Moving In Thursday's Mid-Day Session
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering. 
Via Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Record Quarterly Revenues in Q1 2022
Via Investor Brand Network
Is Dario (DRIO) Health Eating Teladoc's (TDOC) Lunch? Q1 Earnings on Tap Thursday After Meeting with Sanofi (SNY)
Teladoc (NYSE: TDOC) stock recently cratered to a new 52 week low following it’s Q1 report. Some of it’s shortfall was attributed by management to longer sales cycles in the insurer and employer space... 
Via Benzinga
Earnings Outlook For DarioHealth
DarioHealth (NASDAQ:DRIO) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that DarioHealth... 
Via Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Scheduled Release of Q1 2022 Results, Conference Call
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Presents Research Supporting ‘Digital Solutions That Prioritize a Whole Health Experience’
Via Investor Brand Network
This Digital Healthcare Company Is Reporting Multiple New Contracts That It Hopes Might Take It To New Levels
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. The year may have kicked off with a... 
Via Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) to Provide Digital Solutions for Health Plan Colorado Access
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Secures Additional Employer Contracts
Via Investor Brand Network
DarioHealth's Return On Capital Employed Overview
According to Benzinga Pro data, during Q4, DarioHealth (NASDAQ:DRIO) posted sales of $6.03 million. Earnings were up 3.82%, but DarioHealth still reported an overall loss of $21.... 
Via Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Releases Q4, Full-Year 2021 Financial Report, Operational Update
Via Investor Brand Network
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Allarity Therapeutics (NASDAQ:ALLR) stock rose 25.3% to $2.84 during Monday's after-market session. The market value of their outstanding shares is at $22.9 million. 
Via Benzinga
Earnings Scheduled For March 21, 2022
Companies Reporting Before The Bell • Marinus Pharmaceuticals (NASDAQ:MRNS) is likely to report quarterly loss at $0.76 per share on revenue of $3.37 million. •... 
Via Benzinga
The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings
Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment... 
Via Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Scheduled Release of Q4 and Full Year 2021 Results
Via Investor Brand Network
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers CVRx (NASDAQ:CVRX) shares rose 11.6% to $7.2 during Friday's after-market session. The market value of their outstanding shares is at $156.2 million. 
Via Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Adds Two New Contracts to Growing Number of Clients
Via Investor Brand Network
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.